References
- Bavi P, Uddin S, Ahmed M, et al (2011). Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma. Am J Pathol, 178, 2109-20. https://doi.org/10.1016/j.ajpath.2011.01.034
- Berlingieri MT, Pallante P, Guida M, et al (2007). UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. Oncogene, 26, 2136-40. https://doi.org/10.1038/sj.onc.1210010
- Berlingieri MT, Pallante P, Guida M, et al (2007). UbcH10 is overexpressed in malignant breast carcinomas. Eur J Cancer, 43, 2729-35. https://doi.org/10.1016/j.ejca.2007.09.003
- Bernhard EJ, Gruber SB, Muschel RJ (1994). Direct evidence linking expression of matrix metalloproteinase 9 to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA, 91, 4293-7. https://doi.org/10.1073/pnas.91.10.4293
- Bhaskarapillai B, Kumar SS, Balasubramanian S (2012). Lung cancer in Malabar Cancer Center in Kerala-a descriptive analysis. Asian Pacific J Cancer Prev, 13, 4639-43. https://doi.org/10.7314/APJCP.2012.13.9.4639
- Bose MV, Gopisetty G, Selvaluxmy G, Rajkumar T (2012). Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation. Int J Radiat Biol, 88, 629-34. https://doi.org/10.3109/09553002.2012.702299
- Chen S, Chen Y, Hu C, et al (2010). Association of clinicopathological features with UbcH10 expression in colorectal cancer. J Cancer Res Clin Oncol, 136, 419-26. https://doi.org/10.1007/s00432-009-0672-7
- Fujita T, Ikeda H, Taira N, et al (2009). Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer. BMC Cancer, 9, 87-96. https://doi.org/10.1186/1471-2407-9-87
- Hsu JY, Reimann JD, Sorensen CS, Lukas J, Jackson PK (2002). E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC (Cdh1). Nat Cell Biol, 4, 358-66. https://doi.org/10.1038/ncb785
- Ieta K, Ojima E, Tanaka F, et al (2007). Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. Int J Cancer, 121, 33-8. https://doi.org/10.1002/ijc.22605
- Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics. CA Cancer J Clin, 58, 71-96. https://doi.org/10.3322/CA.2007.0010
- Jiang L, Bao Y, Luo C, et al (2010). Knockdown of ubiquitin -conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro. J Cancer Res Clin Oncol, 136, 211-7. https://doi.org/10.1007/s00432-009-0651-z
- Jiang L, Huang CG, Lu YC, et al (2008). Expression of ubiquitinconjugating enzyme E2C/UbcH10 in astrocytic tumors. Brain Res, 1201, 161-6. https://doi.org/10.1016/j.brainres.2008.01.037
- Lin J, Raoof DA, Wang Z, et al (2006). Expression and effect of inhibition of the ubiquitinconjugating enzyme E2C on esophageal adenocarcinoma. Neoplasia, 8, 1062-71. https://doi.org/10.1593/neo.05832
- Nagase H, Woessnerjr JF (1999). Matrix metalloproteinases. J Biol Chem, 274, 21491-4. https://doi.org/10.1074/jbc.274.31.21491
- Okamoto Y, Ozaki T, Miyazaki K, et al (2003). UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res, 63, 4167-73.
- Pallante P, Berlingieri MT, Troncone G, et al (2005). UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer, 93, 464-71. https://doi.org/10.1038/sj.bjc.6602721
- Perrotta I, Bruno L, Maltese L, et al (2012). Immunohistochemical analysis of the ubiquitin -conjugating enzyme UbcH10 in lung cancer: a useful tool for diagnosis and therapy. J Histochem Cytochem, 60, 359-65. https://doi.org/10.1369/0022155412439717
- Reimann JD, Freed E, Hsu JY, Kramer ER, Peters JM (2001). Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell, 105, 645-55. https://doi.org/10.1016/S0092-8674(01)00361-0
- Rizzi A, Tondini M, Rocco G, et al (1990). Lung cancer with a single brain metastasis: therapeutic options. Tumori, 76, 579-89.
- Troncone G, Guerriero E, Pallante P, et al (2009). UbcH10 expression in human lymphomas. Histopathology, 54, 731-40. https://doi.org/10.1111/j.1365-2559.2009.03296.x
- Westermarck J, Kahari VM (1999). Regulation of matrix metallo-proteinase expression in tumor invasion. FASEB J, 13, 781-92. https://doi.org/10.1096/fasebj.13.8.781
- Zhao L, Jiang L, Wang L, et al (2012). UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer. J Cancer Res Clin Oncol, 138, 1951-61. https://doi.org/10.1007/s00432-012-1275-2
- Zahir ST, Mirtalebi M (2012). Survival of patients with lung cancer, Yazd, Iran. Asian Pacific J Cancer Prev, 13, 4387- 91. https://doi.org/10.7314/APJCP.2012.13.9.4387
Cited by
- UBE2Q1 in a Human Breast Carcinoma Cell Line: Overexpression and Interaction with p53 vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3723
- The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data vol.17, pp.1, 2017, https://doi.org/10.1186/s12935-017-0455-1
- Induction of cell proliferation, clonogenicity and cell accumulation in S phase as a consequence of human UBE2Q1 overexpression vol.12, pp.3, 2016, https://doi.org/10.3892/ol.2016.4860
- Oral administration of oat beta-glucan preparations of different molecular weight results in regulation of genes connected with immune response in peripheral blood of rats with LPS-induced enteritis pp.1436-6215, 2018, https://doi.org/10.1007/s00394-018-1838-3
- UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability vol.9, pp.1663-9812, 2018, https://doi.org/10.3389/fphar.2018.00847